Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts
17 Dezembro 2019 - 12:00PM
Business Wire
Pfizer Inc. (NYSE: PFE) invites investors and the general public
to view and listen to a webcast of a conference call with
investment analysts at 10 a.m. EST on Tuesday, January 28, 2020.
The purpose of the call is to provide an update on Pfizer’s
results, as reflected in the company’s Fourth Quarter 2019
Performance Report, to be issued that morning.
To view and listen to the webcast and view the Performance
Report, visit our web site at www.pfizer.com/investors. Information
on accessing and pre-registering for the webcast will be available
at www.pfizer.com/investors beginning today. Participants are
advised to pre-register in advance of the conference call.
You can also listen to the conference call by dialing either
(877) 825-3082 in the United States and Canada or (270) 215-9225
outside of the United States and Canada. The password is “Fourth
Quarter Earnings”.
Visitors to www.pfizer.com/investors will be able to view and
listen to an archived copy of the webcast of the conference
call.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our
anticipated future operating and financial performance, business
plans and prospects, expectations for our product pipeline, in-line
products and product candidates, strategic reviews, capital
allocation objectives, business-development plans, benefits
anticipated from the reorganization of our commercial operations in
2019, plans for and prospects of our acquisitions and other
business development activities, including our proposed transaction
with Mylan N.V. (Mylan) to combine Upjohn and Mylan to create a new
global pharmaceutical company, our acquisition of Array BioPharma
Inc. and our transaction with GSK to combine our respective
consumer healthcare businesses into a new consumer healthcare joint
venture, our ability to successfully capitalize on growth
opportunities or prospects, manufacturing and product supply and
plans relating to share repurchases and dividends, among other
things, that are subject to substantial risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied by such statements. A description of these
risks and uncertainties can be found in Pfizer’s Annual Report on
Form 10-K for the fiscal year ended December 31, 2018 and in its
subsequent reports on Form 10-Q, including in the sections thereof
captioned “Risk Factors” and “Forward-Looking Information and
Factors That May Affect Future Results”, as well as in its
subsequent reports on Form 8-K, all of which are filed with the
U.S. Securities and Exchange Commission and available at
www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 150 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191217005001/en/
Media Relations:
Patricia Kelly
+1 (212) 733-3810
Patricia.Kelly@Pfizer.com
Investor Relations:
Ryan Crowe +1 (212) 733-8160 Ryan.Crowe@Pfizer.com
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024